Global Pharmaceuticals & Biotech Mid-Large Cap Stocks

Neurocrine Biosciences

Market Cap: US$11.9b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

SK Biopharmaceuticals

Market Cap: ₩7.0t

A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.

PharmaEssentia

Market Cap: NT$166.9b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

GNI Group

Market Cap: JP¥149.2b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Celltrion Pharm

Market Cap: ₩2.0t

A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.

MGI Tech

Market Cap: CN¥30.4b

Engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries.

Shanghai Henlius Biotech

Market Cap: HK$22.9b

Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.

Sinocelltech Group

Market Cap: CN¥17.5b

A biotech company, engages in the research and development, and industrialization of recombinant proteins, monoclonal antibodies, and innovative vaccines in China.

Polaris Group

Market Cap: NT$31.1b

Offers biotechnology, drug testing, and contract development and manufacturing services.

Mankind Pharma

Market Cap: ₹1.0t

Develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally.

Genmab

Market Cap: DKK 86.2b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

ABL Bio

Market Cap: ₩3.1t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

Emcure Pharmaceuticals

Market Cap: ₹243.4b

Engages in the developing, manufacturing, and marketing pharmaceutical products worldwide.

Duality Biotherapeutics

Market Cap: HK$18.8b

Duality Biotherapeutics Inc., a clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.

Caliway Biopharmaceuticals

Market Cap: NT$137.0b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

RemeGen

Market Cap: HK$31.6b

A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.

Hansoh Pharmaceutical Group

Market Cap: HK$152.5b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Luye Pharma Group

Market Cap: HK$8.3b

Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.

Neuren Pharmaceuticals

Market Cap: AU$1.6b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

Hugel

Market Cap: ₩3.8t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

ALTEOGEN

Market Cap: ₩17.2t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Oxford Nanopore Technologies

Market Cap: UK£1.2b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA.

Eurofins Scientific

Market Cap: €10.2b

Provides various analytical testing and laboratory services worldwide.

Vitrolife

Market Cap: SEK 20.2b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Galapagos

Market Cap: €1.7b

A biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe.

Bonesupport Holding

Market Cap: SEK 17.4b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Bayer

Market Cap: €23.9b

Operates as a life science company worldwide.

Kuros Biosciences

Market Cap: CHF 945.5m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

UCB

Market Cap: €30.5b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

BridgeBio Pharma

Market Cap: US$6.2b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Trulieve Cannabis

Market Cap: CA$14.8b

Operates as a cannabis retailer.

Rhythm Pharmaceuticals

Market Cap: US$4.0b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

BeiGene

Market Cap: US$25.6b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Krystal Biotech

Market Cap: US$3.7b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Janux Therapeutics

Market Cap: US$1.5b

A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.

ANI Pharmaceuticals

Market Cap: US$1.2b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.